Focus topics


Cancer Therapy: Pharmaceutical Companies want to shake up the World Market

When it comes to new cancer drugs, China has recently shown particular promise in the checkpoint inhibitor segment. This therapy, which supports the immune system’s defense reaction against tumor tissue, is used both as monotherapy and in combination with chemotherapy.

Continue reading now

Get 30 days of free access to the Decision Brief to read these and more quality news every day.

Are you already a guest at the China.Table? Log in now

Related

    Yuan at all-time low
    Porsche hopes for cult following
    AI to mitigate risk of blackouts
    Box-office hit ‘Return to Dust’: Too authentic for Beijing